Thursday, 31 December 2009

Amfépramone




Amfépramone may be available in the countries listed below.


Ingredient matches for Amfépramone



Amfepramone

Amfépramone (DCF) is also known as Amfepramone (Prop.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Prop.INNProposed International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, 28 December 2009

Oxacilline Sodique




Oxacilline Sodique may be available in the countries listed below.


Ingredient matches for Oxacilline Sodique



Oxacillin

Oxacillin is reported as an ingredient of Oxacilline Sodique in the following countries:


  • Tunisia

International Drug Name Search

Sunday, 27 December 2009

Clamicil




Clamicil may be available in the countries listed below.


Ingredient matches for Clamicil



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Clamicil in the following countries:


  • Colombia

  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Clamicil in the following countries:


  • Colombia

  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

International Drug Name Search

Tuesday, 22 December 2009

Zemicef




Zemicef may be available in the countries listed below.


Ingredient matches for Zemicef



Ceftriaxone

Ceftriaxone is reported as an ingredient of Zemicef in the following countries:


  • Bangladesh

International Drug Name Search

Sunday, 20 December 2009

Cetirizin-Teva




Cetirizin-Teva may be available in the countries listed below.


Ingredient matches for Cetirizin-Teva



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cetirizin-Teva in the following countries:


  • Germany

  • Switzerland

International Drug Name Search

Saturday, 19 December 2009

Vetren




Vetren may be available in the countries listed below.


Ingredient matches for Vetren



Heparin

Heparin sodium salt (a derivative of Heparin) is reported as an ingredient of Vetren in the following countries:


  • Austria

  • Germany

International Drug Name Search

Wednesday, 16 December 2009

Panadol Night




Panadol Night may be available in the countries listed below.


Ingredient matches for Panadol Night



Diphenhydramine

Diphenhydramine hydrochloride (a derivative of Diphenhydramine) is reported as an ingredient of Panadol Night in the following countries:


  • New Zealand

Paracetamol

Paracetamol is reported as an ingredient of Panadol Night in the following countries:


  • New Zealand

International Drug Name Search

Sunday, 13 December 2009

Lontadex




Lontadex may be available in the countries listed below.


Ingredient matches for Lontadex



Loratadine

Loratadine is reported as an ingredient of Lontadex in the following countries:


  • Chile

International Drug Name Search

Thursday, 10 December 2009

Alfuzosina Ur




Alfuzosina Ur may be available in the countries listed below.


Ingredient matches for Alfuzosina Ur



Alfuzosin

Alfuzosin hydrochloride (a derivative of Alfuzosin) is reported as an ingredient of Alfuzosina Ur in the following countries:


  • Spain

International Drug Name Search

Tuesday, 8 December 2009

Perdox




Perdox may be available in the countries listed below.


Ingredient matches for Perdox



Risperidone

Risperidone is reported as an ingredient of Perdox in the following countries:


  • Hungary

International Drug Name Search

Alendroninezuur Sandoz




Alendroninezuur Sandoz may be available in the countries listed below.


Ingredient matches for Alendroninezuur Sandoz



Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Alendroninezuur Sandoz in the following countries:


  • Netherlands

International Drug Name Search

Wednesday, 2 December 2009

Pectorhinyl




Pectorhinyl may be available in the countries listed below.


Ingredient matches for Pectorhinyl



Phenylephrine

Phenylephrine hydrochloride (a derivative of Phenylephrine) is reported as an ingredient of Pectorhinyl in the following countries:


  • Luxembourg

Pholcodine

Pholcodine is reported as an ingredient of Pectorhinyl in the following countries:


  • Luxembourg

International Drug Name Search

Tuesday, 1 December 2009

Maxidazol




Maxidazol may be available in the countries listed below.


Ingredient matches for Maxidazol



Secnidazole

Secnidazole is reported as an ingredient of Maxidazol in the following countries:


  • Dominican Republic

International Drug Name Search

Wednesday, 25 November 2009

Carbamazepina Normon




Carbamazepina Normon may be available in the countries listed below.


Ingredient matches for Carbamazepina Normon



Carbamazepine

Carbamazepine is reported as an ingredient of Carbamazepina Normon in the following countries:


  • Costa Rica

  • Dominican Republic

  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

  • Panama

  • Spain

International Drug Name Search

Friday, 20 November 2009

Metotrexato Wyeth




Metotrexato Wyeth may be available in the countries listed below.


Ingredient matches for Metotrexato Wyeth



Methotrexate

Methotrexate sodium salt (a derivative of Methotrexate) is reported as an ingredient of Metotrexato Wyeth in the following countries:


  • Spain

International Drug Name Search

Thursday, 19 November 2009

Furosémide Sandoz




Furosémide Sandoz may be available in the countries listed below.


Ingredient matches for Furosémide Sandoz



Furosemide

Furosemide is reported as an ingredient of Furosémide Sandoz in the following countries:


  • France

International Drug Name Search

Doxyfene




Doxyfene may be available in the countries listed below.


Ingredient matches for Doxyfene



Dextropropoxyphene

Dextropropoxyphene is reported as an ingredient of Doxyfene in the following countries:


  • South Africa

Paracetamol

Paracetamol is reported as an ingredient of Doxyfene in the following countries:


  • South Africa

International Drug Name Search

Wednesday, 18 November 2009

Ciproterona acetato




Ciproterona acetato may be available in the countries listed below.


Ingredient matches for Ciproterona acetato



Cyproterone

Cyproterone 17α-acetate (a derivative of Cyproterone) is reported as an ingredient of Ciproterona acetato in the following countries:


  • Colombia

International Drug Name Search

Tuesday, 17 November 2009

Tradox




Tradox may be available in the countries listed below.


Ingredient matches for Tradox



Lamotrigine

Lamotrigine is reported as an ingredient of Tradox in the following countries:


  • Chile

International Drug Name Search

Monday, 16 November 2009

Folotyn




In the US, Folotyn (pralatrexate systemic) is a member of the drug class antimetabolites and is used to treat Lymphoma and Non-Hodgkin's Lymphoma.

US matches:

  • Folotyn

Ingredient matches for Folotyn



Pralatrexate

Pralatrexate is reported as an ingredient of Folotyn in the following countries:


  • United States

International Drug Name Search

Anca




Anca may be available in the countries listed below.


Ingredient matches for Anca



Cefprozil

Cefprozil is reported as an ingredient of Anca in the following countries:


  • Bangladesh

International Drug Name Search

Sunday, 15 November 2009

Cefuroxim-1A Pharma




Cefuroxim-1A Pharma may be available in the countries listed below.


Ingredient matches for Cefuroxim-1A Pharma



Cefuroxime

Cefuroxime is reported as an ingredient of Cefuroxim-1A Pharma in the following countries:


  • Latvia

Cefuroxime axetil (a derivative of Cefuroxime) is reported as an ingredient of Cefuroxim-1A Pharma in the following countries:


  • Austria

  • Germany

  • Hungary

International Drug Name Search

Saturday, 14 November 2009

Procain DeltaSelect




Procain DeltaSelect may be available in the countries listed below.


Ingredient matches for Procain DeltaSelect



Procaine

Procaine hydrochloride (a derivative of Procaine) is reported as an ingredient of Procain DeltaSelect in the following countries:


  • Germany

International Drug Name Search

Thursday, 12 November 2009

Grüncef




Grüncef may be available in the countries listed below.


Ingredient matches for Grüncef



Cefadroxil

Cefadroxil monohydrate (a derivative of Cefadroxil) is reported as an ingredient of Grüncef in the following countries:


  • Germany

International Drug Name Search

Tuesday, 10 November 2009

Cefaclor Ranbaxy




Cefaclor Ranbaxy may be available in the countries listed below.


Ingredient matches for Cefaclor Ranbaxy



Cefaclor

Cefaclor monohydrate (a derivative of Cefaclor) is reported as an ingredient of Cefaclor Ranbaxy in the following countries:


  • Spain

International Drug Name Search

Monday, 9 November 2009

Enalapril / Hydrochloorthiazide CF




Enalapril / Hydrochloorthiazide CF may be available in the countries listed below.


Ingredient matches for Enalapril / Hydrochloorthiazide CF



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril / Hydrochloorthiazide CF in the following countries:


  • Netherlands

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Enalapril / Hydrochloorthiazide CF in the following countries:


  • Netherlands

International Drug Name Search

Slim




Slim may be available in the countries listed below.


Ingredient matches for Slim



Sibutramine

Sibutramine hydrochloride monohydrate (a derivative of Sibutramine) is reported as an ingredient of Slim in the following countries:


  • Bangladesh

International Drug Name Search

Friday, 6 November 2009

Dicorynan




Dicorynan may be available in the countries listed below.


Ingredient matches for Dicorynan



Disopyramide

Disopyramide is reported as an ingredient of Dicorynan in the following countries:


  • Greece

  • Spain

International Drug Name Search

Sunday, 1 November 2009

Hoestdrank Broomhexine HCl




Hoestdrank Broomhexine HCl may be available in the countries listed below.


Ingredient matches for Hoestdrank Broomhexine HCl



Bromhexine

Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Hoestdrank Broomhexine HCl in the following countries:


  • Netherlands

International Drug Name Search

Monday, 26 October 2009

Tamsulosina Pliva




Tamsulosina Pliva may be available in the countries listed below.


Ingredient matches for Tamsulosina Pliva



Tamsulosin

Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Tamsulosina Pliva in the following countries:


  • Italy

International Drug Name Search

Thursday, 22 October 2009

Amethocaine




Amethocaine may be available in the countries listed below.


Ingredient matches for Amethocaine



Tetracaine

Amethocaine (BAN) is known as Tetracaine in the US.

International Drug Name Search

Glossary

BANBritish Approved Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 21 October 2009

Istin




Istin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

UK matches:

  • Istin (SPC)

Ingredient matches for Istin



Amlodipine

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Istin in the following countries:


  • Ireland

  • Malta

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 20 October 2009

Procarbazine




In the US, Procarbazine (procarbazine systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Glioblastoma Multiforme and Hodgkin's Lymphoma.

US matches:

  • Procarbazine

  • Procarbazine Hydrochloride

UK matches:

  • Procarbazine Capsules 50mg (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XB01

CAS registry number (Chemical Abstracts Service)

0000671-16-9

Chemical Formula

C12-H19-N3-O

Molecular Weight

221

Therapeutic Category

Antineoplastic agent

Chemical Name

Benzamide, N-(1-methylethyl)-4-[(2-methylhydrazino)methyl]-

Foreign Names

  • Procarbazinum (Latin)
  • Procarbazin (German)
  • Procarbazine (French)
  • Procarbazina (Spanish)

Generic Names

  • Procarbazina (OS: DCIT)
  • Procarbazine (OS: BAN, DCF)
  • Ibenzmethyzine (IS)
  • Procarbazine Hydrochloride (OS: USAN, JAN)
  • NSC 77213 (IS)
  • PRO (IS)
  • Ro 4-6467 (IS)
  • Procarbazine Hydrochloride (PH: Ph. Int. 4, USP 32, JP XIV)
  • Procarbazini hydrochloridum (PH: Ph. Int. 4)

Brand Names

  • Matulane
    Sigma Tau, Canada; Sigma Tau, United States


  • Natulan
    Link, Australia; Pharma Riace, Russian Federation; Roche, Ethiopia; Sigma, Netherlands; Sigma Tau, Spain; Sigma Tau, France; Sigma Tau, Italy; Sigma-Tau, Switzerland; Sigma-Tau, Germany


  • Procarbazine
    AFT, New Zealand; Cambridge Laboratories, United Kingdom

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
SPC Summary of Product Characteristics (UK)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, 19 October 2009

Cedilanide




Cedilanide may be available in the countries listed below.


Ingredient matches for Cedilanide



Deslanoside

Deslanoside is reported as an ingredient of Cedilanide in the following countries:


  • Brazil

International Drug Name Search

Promazin Jelfa




Promazin Jelfa may be available in the countries listed below.


Ingredient matches for Promazin Jelfa



Promazine

Promazine hydrochloride (a derivative of Promazine) is reported as an ingredient of Promazin Jelfa in the following countries:


  • Poland

International Drug Name Search

Saturday, 17 October 2009

Procefa




Procefa may be available in the countries listed below.


Ingredient matches for Procefa



Cefotaxime

Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Procefa in the following countries:


  • Indonesia

International Drug Name Search

Wednesday, 14 October 2009

Pentilin




Pentilin may be available in the countries listed below.


Ingredient matches for Pentilin



Pentoxifylline

Pentoxifylline is reported as an ingredient of Pentilin in the following countries:


  • Bosnia & Herzegowina

  • Croatia (Hrvatska)

  • Czech Republic

  • Estonia

  • Latvia

  • Lithuania

  • Poland

  • Serbia

  • Slovenia

International Drug Name Search

Monday, 12 October 2009

Pantames




Pantames may be available in the countries listed below.


Ingredient matches for Pantames



Nimesulide

Nimesulide is reported as an ingredient of Pantames in the following countries:


  • Italy

International Drug Name Search

Magnesie Plus




Magnesie Plus may be available in the countries listed below.


Ingredient matches for Magnesie Plus



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Magnesie Plus in the following countries:


  • Belgium

Magnesium Carbonate

Magnesium Carbonate is reported as an ingredient of Magnesie Plus in the following countries:


  • Belgium

Sodium Bicarbonate

Sodium Bicarbonate is reported as an ingredient of Magnesie Plus in the following countries:


  • Belgium

International Drug Name Search

Venex




Venex may be available in the countries listed below.


Ingredient matches for Venex



Diosmin

Diosmin is reported as an ingredient of Venex in the following countries:


  • Portugal

Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Venex in the following countries:


  • Ireland

International Drug Name Search

Sunday, 11 October 2009

Isosorbide dinitraat Ratiopharm




Isosorbide dinitraat Ratiopharm may be available in the countries listed below.


Ingredient matches for Isosorbide dinitraat Ratiopharm



Isosorbide Dinitrate

Isosorbide Dinitrate is reported as an ingredient of Isosorbide dinitraat Ratiopharm in the following countries:


  • Netherlands

International Drug Name Search

Saturday, 10 October 2009

Dobendan




Dobendan may be available in the countries listed below.


Ingredient matches for Dobendan



Cetylpyridinium

Cetylpyridinium chloride (a derivative of Cetylpyridinium) is reported as an ingredient of Dobendan in the following countries:


  • Austria

Cetylpyridinium chloride monohydrate (a derivative of Cetylpyridinium) is reported as an ingredient of Dobendan in the following countries:


  • Germany

International Drug Name Search

Thursday, 8 October 2009

GenRX Gemfibrozil




GenRX Gemfibrozil may be available in the countries listed below.


Ingredient matches for GenRX Gemfibrozil



Gemfibrozil

Gemfibrozil is reported as an ingredient of GenRX Gemfibrozil in the following countries:


  • Australia

International Drug Name Search

Allobenz




Allobenz may be available in the countries listed below.


Ingredient matches for Allobenz



Allopurinol

Allopurinol is reported as an ingredient of Allobenz in the following countries:


  • Austria

Benzbromarone

Benzbromarone is reported as an ingredient of Allobenz in the following countries:


  • Austria

International Drug Name Search

Tuesday, 6 October 2009

Primum




Primum may be available in the countries listed below.


Ingredient matches for Primum



Flunitrazepam

Flunitrazepam is reported as an ingredient of Primum in the following countries:


  • Argentina

International Drug Name Search

Sunday, 4 October 2009

Bio-Statin


Generic Name: nystatin (Oral route)

nye-STAT-in

Commonly used brand name(s)

In the U.S.


  • Bio-Statin

In Canada


  • Mycostatin Suspension

  • Nadostine

  • Nadostine Sucrose-Free

  • Nilstat Drops

  • Nilstat Powder

  • Nyaderm

  • Pms-Nystatin

Available Dosage Forms:


  • Capsule

  • Tablet

  • Suspension

Therapeutic Class: Antifungal


Chemical Class: Polyene


Uses For Bio-Statin


Nystatin belongs to the group of medicines called antifungals. The dry powder, lozenge (pastille), and liquid forms of this medicine are used to treat fungus infections in the mouth.


Nystatin is available only with your doctor's prescription.


Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although this use is not included in product labeling, nystatin is used in certain patients with the following medical condition:


  • Candidiasis, oral (fungus infection of the mouth) (prevention)

Before Using Bio-Statin


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


This medicine has been tested in children and has not been reported to cause different side effects or problems in children than it does in adults. However, since children up to 5 years of age may be too young to use the lozenges (pastilles) or tablets safely, the oral suspension dosage form is best for this age group.


Geriatric


Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of oral nystatin in the elderly with use in other age groups.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Proper Use of nystatin

This section provides information on the proper use of a number of products that contain nystatin. It may not be specific to Bio-Statin. Please read with care.


For patients taking the dry powder form of nystatin:


  • Add about ⅛ teaspoonful of dry powder to about 4 ounces of water immediately before taking. Stir well.

  • After it is mixed, take this medicine by dividing the whole amount (4 ounces) into several portions. Hold each portion of the medicine in your mouth or swish it around in your mouth for as long as possible, gargle, and swallow. Be sure to use all the liquid to get the full dose of medicine.

For patients taking the lozenge (pastille) form of nystatin:


  • Nystatin lozenges (pastilles) should be held in the mouth and allowed to dissolve slowly and completely. This may take 15 to 30 minutes. Also, the saliva should be swallowed during this time. Do not chew or swallow the lozenges whole.

  • Do not give nystatin lozenges (pastilles) to infants or children up to 5 years of age. They may be too young to use the lozenges safely.

For patients taking the oral liquid form of nystatin :


  • This medicine is to be taken by mouth even if it comes in a dropper bottle. If it does come in a dropper bottle, use the specially marked dropper to measure each dose accurately.

  • Take this medicine by placing one-half of the dose in each side of your mouth. Hold the medicine in your mouth or swish it around in your mouth for as long as possible, then gargle and swallow.

Patients with full or partial dentures may need to soak their dentures nightly in nystatin for oral suspension to eliminate the fungus from the dentures. In rare cases when this does not eliminate the fungus, it may be necessary to have new dentures made.


To help clear up your infection completely, keep taking this medicine for the full time of treatment, even if your condition has improved. Do not miss any doses.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For the lozenge (pastille) and tablet dosage forms:
    • Adults and children 5 years of age and older: 1 or 2 lozenges or tablets three to five times a day for up to fourteen days.

    • Children up to 5 years of age: Children this young may not be able to use the lozenges or tablets safely. The oral suspension is better for this age group.


  • For the suspension dosage form:
    • Adults and children 5 years of age and older: 4 to 6 milliliters (mL) (about 1 teaspoonful) four times a day.

    • For older infants: 2 mL four times a day.

    • For premature and low-birth-weight infants: 1 mL four times a day.


Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Store the lozenge (pastille) form in the refrigerator.


Bio-Statin Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Diarrhea

  • nausea or vomiting

  • stomach pain

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Bio-Statin side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Bio-Statin resources


  • Bio-Statin Side Effects (in more detail)
  • Bio-Statin Use in Pregnancy & Breastfeeding
  • Bio-Statin Drug Interactions
  • Bio-Statin Support Group
  • 0 Reviews for Bio-Statin - Add your own review/rating


  • Bio-Statin Powder MedFacts Consumer Leaflet (Wolters Kluwer)

  • Bio-Statin Concise Consumer Information (Cerner Multum)

  • Nystatin Professional Patient Advice (Wolters Kluwer)

  • Nystatin Monograph (AHFS DI)

  • Nystatin MedFacts Consumer Leaflet (Wolters Kluwer)

  • Mycostatin Prescribing Information (FDA)

  • Mycostatin MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Bio-Statin with other medications


  • Gastrointestinal Candidiasis
  • Oral Thrush

Vasolator




Vasolator may be available in the countries listed below.


Ingredient matches for Vasolator



Nitroglycerin

Nitroglycerin is reported as an ingredient of Vasolator in the following countries:


  • Japan

International Drug Name Search

Friday, 2 October 2009

Helvevir




Helvevir may be available in the countries listed below.


Ingredient matches for Helvevir



Acyclovir

Aciclovir is reported as an ingredient of Helvevir in the following countries:


  • Switzerland

International Drug Name Search

Thursday, 1 October 2009

Dextropropoxyphène Paracétamol Almus




Dextropropoxyphène Paracétamol Almus may be available in the countries listed below.


Ingredient matches for Dextropropoxyphène Paracétamol Almus



Dextropropoxyphene

Dextropropoxyphene hydrochloride (a derivative of Dextropropoxyphene) is reported as an ingredient of Dextropropoxyphène Paracétamol Almus in the following countries:


  • France

Paracetamol

Paracetamol is reported as an ingredient of Dextropropoxyphène Paracétamol Almus in the following countries:


  • France

International Drug Name Search

Monday, 28 September 2009

Reuxen




Reuxen may be available in the countries listed below.


Ingredient matches for Reuxen



Naproxen

Naproxen is reported as an ingredient of Reuxen in the following countries:


  • Portugal

  • Romania

International Drug Name Search

Neodol




Neodol may be available in the countries listed below.


Ingredient matches for Neodol



Diclofenac

Diclofenac potassium salt (a derivative of Diclofenac) is reported as an ingredient of Neodol in the following countries:


  • Myanmar

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Neodol in the following countries:


  • Sri Lanka

International Drug Name Search

Normastigmin




Normastigmin may be available in the countries listed below.


Ingredient matches for Normastigmin



Neostigmine

Neostigmine metilsulfate (a derivative of Neostigmine) is reported as an ingredient of Normastigmin in the following countries:


  • Austria

International Drug Name Search

Sunday, 27 September 2009

Eau oxygénée Gifrer




Eau oxygénée Gifrer may be available in the countries listed below.


Ingredient matches for Eau oxygénée Gifrer



Hydrogen Peroxide

Hydrogen Peroxide is reported as an ingredient of Eau oxygénée Gifrer in the following countries:


  • France

International Drug Name Search

Saturday, 26 September 2009

Onxol


Generic Name: paclitaxel (Intravenous route)

pak-li-TAX-el

Intravenous route(Solution)

Anaphylaxis and severe hypersensitivity reactions characterized by dyspnea and hypotension requiring treatment, angioedema, and generalized urticaria have occurred in clinical trials. Fatal reactions have occurred in patients despite premedication and all patients should be pretreated with corticosteroids, diphenhydramine, and H(2) antagonists. Patients who experience severe hypersensitivity reactions to paclitaxel should not be rechallenged with the drug. Paclitaxel therapy should not be given to patients with solid tumors who have baseline neutrophil counts of less than 1500 cells/mm(3) and should not be given to patients with AIDS-related Kaposi's sarcoma if the baseline neutrophil count is less than 1000 cells/mm(3). Monitor peripheral blood cell counts frequently .



Commonly used brand name(s)

In the U.S.


  • Nov-Onxol

  • Onxol

  • Paclitaxel Novaplus

  • Taxol

Available Dosage Forms:


  • Solution

Therapeutic Class: Antineoplastic Agent


Pharmacologic Class: Mitotic Inhibitor


Uses For Onxol


Paclitaxel injection is used to treat advanced cancer of the ovaries, breast, non-small cell lung cancer, and Kaposi sarcoma. Kaposi sarcoma is a cancer of the skin and mucous membranes that is commonly found in patients with acquired immunodeficiency syndrome (AIDS).


Paclitaxel belongs to the group of medicines called antineoplastics. It interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected, other unwanted effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects may not be serious but may cause concern. Some effects may not occur until months or years after the medicine is used.


Before you begin treatment with paclitaxel, you and your doctor should talk about the good this medicine will do as well as the risks of using it.


This medicine is to be administered only by or under the immediate supervision of your doctor.


Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, paclitaxel is used in certain patients with the following medical conditions:


  • Cancer of the bladder.

  • Cancer of the cervix.

  • Cancer of the endometrium.

  • Cancer of the esophagus.

  • Cancer of the fallopian tube or lining of the abdomen (spreading from the ovary).

  • Cancers of the head and neck.

  • Cancer of the prostate.

  • Cancer of the stomach

  • Cancer of the testes.

  • Cancer of unknown primary site.

  • Small cell lung cancer (a certain type found in the tissues of the lungs).

Before Using Onxol


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of paclitaxel injection in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of paclitaxel injection in the elderly. However, elderly patients are more likely to have unwanted side effects (e.g., heart disease, bone marrow problems, and nerve problems), which may require caution in patients receiving paclitaxel injection.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersDStudies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy in a life threatening situation or a serious disease, may outweigh the potential risk.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Rotavirus Vaccine, Live

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Adenovirus Vaccine Type 4, Live

  • Adenovirus Vaccine Type 7, Live

  • Aprepitant

  • Bacillus of Calmette and Guerin Vaccine, Live

  • Bexarotene

  • Cisplatin

  • Deferasirox

  • Doxorubicin Hydrochloride

  • Ethinyl Estradiol

  • Fosaprepitant

  • Infliximab

  • Influenza Virus Vaccine, Live

  • Measles Virus Vaccine, Live

  • Mumps Virus Vaccine, Live

  • Pazopanib

  • Rotavirus Vaccine, Live

  • Rubella Virus Vaccine, Live

  • Smallpox Vaccine

  • St John's Wort

  • Testosterone

  • Tretinoin

  • Typhoid Vaccine

  • Valspodar

  • Varicella Virus Vaccine

  • Yellow Fever Vaccine

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Dalfopristin

  • Doxorubicin Hydrochloride Liposome

  • Epirubicin

  • Fosphenytoin

  • Lapatinib

  • Phenytoin

  • Quinupristin

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Bradycardia (slow heart rate) or

  • Heart rhythm problems or

  • Hypertension (high blood pressure) or

  • Hypotension (low blood pressure) or

  • Peripheral neuropathy (pain, numbness, or tingling of hands, arms, legs, or feet)—Use with caution. May make these conditions worse.

  • Infection—May decrease your body's ability to fight an infection.

  • Liver disease—Use with caution. The effects may be increased because of slower removal of the medicine from the body.

  • Neutropenia, severe (very low white blood cells)—Should not be used in patients with this condition.

Proper Use of paclitaxel

This section provides information on the proper use of a number of products that contain paclitaxel. It may not be specific to Onxol. Please read with care.


Medicines used to treat cancer are very strong and can have many unwanted effects. Before receiving this medicine, you and your doctor should talk about the good this medicine will do as well as the risks of using it. .


A doctor or other trained health professional will give you this medicine in a hospital or cancer treatment center. This medicine is given through a needle placed in one of your veins.


This medicine is usually given every 3 weeks and is used together with other cancer medicines, such as cisplatin or doxorubicin.


You may also receive other medicines to help prevent allergic reactions and nausea or vomiting from paclitaxel.


Precautions While Using Onxol


It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly. Blood tests may be needed to check for unwanted effects.


Using this medicine while you are pregnant can harm your unborn baby. Use an effective form of birth control to keep from getting pregnant. If you think you have become pregnant while using the medicine, tell your doctor right away.


This medicine may cause serious allergic reactions, including anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Tell your doctor or nurse right away if you have a cough; dizziness; wheezing; trouble with breathing; chest or throat tightness; swelling in your face or hands; fever; chills; rash; itching or hives; skin redness; or lightheadedness or faintness while you are receiving this medicine.


While you are being treated with paclitaxel, and after you stop treatment with it, do not have any immunizations (vaccines) without your doctor's approval. Paclitaxel may lower your body's resistance and the vaccine may not work as well or you might get the infection the vaccine is meant to prevent. In addition, you should not be around other persons living in your household who receive live virus vaccines because there is a chance they could pass the virus on to you. Some examples of live vaccines include measles, mumps, influenza (nasal flu vaccine), poliovirus (oral form), rotavirus, and rubella. Do not get close to them and do not stay in the same room with them for very long. If you have questions about this, talk to your doctor.


Paclitaxel can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:


  • If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.

  • Check with your doctor immediately if you notice any unusual bleeding or bruising; black, tarry stools; blood in the urine or stools; or pinpoint red spots on your skin.

  • Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your medical doctor before having any dental work done.

  • Do not touch your eyes or the inside of your nose unless you have just washed your hands and have not touched anything else in the meantime.

  • Be careful not to cut yourself when you are using sharp objects such as a safety razor or fingernail or toenail cutters.

  • Avoid contact sports or other situations where bruising or injury could occur.

This medicine may cause peripheral neuropathy. Check with your doctor right away if you are having burning, numbness, tingling, or painful sensations in the arms, hands, legs, or feet while using this medicine.


Cancer medicines can cause diarrhea, nausea, or vomiting in most people, sometimes even after receiving medicines to prevent it. Ask your doctor or nurse about other ways to control these unwanted effects if you still have nausea or vomiting after receiving the medicine.


Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.


Onxol Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor or nurse immediately if any of the following side effects occur:


More common
  • Black or tarry stools

  • blurred vision

  • burning, numbness, tingling, or painful sensations

  • confusion

  • cough or hoarseness with fever or chills

  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position

  • feeling of warmth

  • fever or chills

  • lower back or side pain

  • painful or difficult urination

  • pale skin

  • redness of the face, neck, arms, and occasionally, upper chest

  • shortness of breath

  • skin rash or itching

  • sore throat

  • sweating

  • troubled breathing with exertion

  • ulcers, sores, or white spots in the mouth

  • unsteadiness or awkwardness

  • unusual bleeding or bruising

  • unusual tiredness or weakness

  • weakness in the arms, hands, legs, or feet

Less common
  • Blood in the urine or stools

  • difficult or labored breathing

  • pinpoint red spots on the skin

  • shortness of breath (severe)

  • slow heartbeat

  • tightness in the chest

  • wheezing

Incidence not known
  • Anxiety

  • blue lips, fingernails, or skin

  • difficult or troubled breathing

  • fainting

  • fast heartbeat

  • irregular, fast or slow, or shallow breathing

  • sudden shortness of breath

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site

  • cracked lips

  • diarrhea

  • difficulty with swallowing

  • hair loss

  • nausea or vomiting

  • numbness, burning, or tingling in the hands or feet

  • pain in the joints or muscles, especially in the arms or legs

  • thinning of the hair

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Onxol side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Onxol resources


  • Onxol Side Effects (in more detail)
  • Onxol Use in Pregnancy & Breastfeeding
  • Onxol Drug Interactions
  • Onxol Support Group
  • 0 Reviews for Onxol - Add your own review/rating


  • Onxol Prescribing Information (FDA)

  • Onxol MedFacts Consumer Leaflet (Wolters Kluwer)

  • Paclitaxel Professional Patient Advice (Wolters Kluwer)

  • Paclitaxel Prescribing Information (FDA)

  • Paclitaxel Monograph (AHFS DI)

  • Paclitaxel MedFacts Consumer Leaflet (Wolters Kluwer)

  • Taxol Prescribing Information (FDA)

  • Taxol Consumer Overview



Compare Onxol with other medications


  • Breast Cancer
  • Breast Cancer, Adjuvant
  • Breast Cancer, Metastatic
  • Kaposi's Sarcoma
  • Non-Small Cell Lung Cancer
  • Ovarian Cancer
  • Wilms' Tumor

Friday, 25 September 2009

Prednipirine




Prednipirine may be available in the countries listed below.


Ingredient matches for Prednipirine



Prednisone

Prednisone is reported as an ingredient of Prednipirine in the following countries:


  • Argentina

International Drug Name Search

Thursday, 24 September 2009

Sepride




Sepride may be available in the countries listed below.


Ingredient matches for Sepride



Cisapride

Cisapride is reported as an ingredient of Sepride in the following countries:


  • Tunisia

International Drug Name Search

Zevamab




Zevamab may be available in the countries listed below.


Ingredient matches for Zevamab



Ibritumomab

Ibritumomab Tiuxetan is reported as an ingredient of Zevamab in the following countries:


  • Argentina

International Drug Name Search

Wednesday, 23 September 2009

Modigraf




Modigraf may be available in the countries listed below.


Ingredient matches for Modigraf



Tacrolimus

Tacrolimus monohydrate (a derivative of Tacrolimus) is reported as an ingredient of Modigraf in the following countries:


  • France

  • Germany

International Drug Name Search

Monday, 21 September 2009

PMS-Metoprolol




PMS-Metoprolol may be available in the countries listed below.


Ingredient matches for PMS-Metoprolol



Metoprolol

Metoprolol tartrate (a derivative of Metoprolol) is reported as an ingredient of PMS-Metoprolol in the following countries:


  • Canada

International Drug Name Search

Sunday, 20 September 2009

Prostandin




Prostandin may be available in the countries listed below.


Ingredient matches for Prostandin



Alprostadil

Alprostadil alfadex (a derivative of Alprostadil) is reported as an ingredient of Prostandin in the following countries:


  • Japan

International Drug Name Search

Friday, 18 September 2009

Sua




Sua may be available in the countries listed below.


Ingredient matches for Sua



Clobetasol

Clobetasol is reported as an ingredient of Sua in the following countries:


  • Peru

International Drug Name Search

Tuesday, 15 September 2009

Kalxetin




Kalxetin may be available in the countries listed below.


Ingredient matches for Kalxetin



Fluoxetine

Fluoxetine is reported as an ingredient of Kalxetin in the following countries:


  • Vietnam

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Kalxetin in the following countries:


  • Indonesia

  • Sri Lanka

International Drug Name Search

Monday, 14 September 2009

Trizac




Trizac may be available in the countries listed below.


Ingredient matches for Trizac



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Trizac in the following countries:


  • Ethiopia

  • Oman

International Drug Name Search

Thursday, 10 September 2009

Aciclovir Stada




Aciclovir Stada may be available in the countries listed below.


Ingredient matches for Aciclovir Stada



Acyclovir

Aciclovir is reported as an ingredient of Aciclovir Stada in the following countries:


  • Spain

International Drug Name Search

Tuesday, 8 September 2009

Perlium Amoxival




Perlium Amoxival may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Perlium Amoxival



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Perlium Amoxival in the following countries:


  • France

International Drug Name Search

Orajel Denture Plus


Generic Name: benzocaine topical (BENZ oh kane TOP ik al)

Brand Names: Americaine, Americaine Hemorrhoidal, Anacaine, Anbesol Gel, Anbesol Liquid, Babee Teething Lotion, Benzo-O-Stetic, Boil Ease Pain Relieving, Cepacol Extra Strength, Cepacol Fizzlers, Dent-O-Kain, Dermoplast, Detane, Hurricaine, Lanacane, Maintain, Medicone Maximum Strength, Num-Zit, Numzident, Orabase, Orabase Gel-B, Orajel, Orajel Denture, Oral Pain Relief, OraMagic Plus, Outgro Pain Relief, Retre-Gel, Rid-A-Pain, Skeeter Stik, Solarcaine Aerosol, Sting-Kill, Topex, Trocaine, Vagisil Feminine Cream, zilactin-B


What is Orajel Denture Plus (benzocaine topical)?

Benzocaine is a local anesthetic (numbing medication). It works by blocking nerve signals in your body.


Benzocaine topical is used to reduce pain or discomfort caused by minor skin irritations, sore throat, sunburn, teething pain, vaginal or rectal irritation, ingrown toenails, hemorrhoids, and many other sources of minor pain on a surface of the body. Benzocaine is also used to numb the skin or surfaces inside the mouth, nose, throat, vagina, or rectum to lessen the pain of inserting a medical instrument such as a tube or speculum.


There are many brands and forms of benzocaine topical available and not all brands are listed on this leaflet.


Benzocaine topical may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Orajel Denture Plus (benzocaine topical)?


There are many brands and forms of benzocaine topical available and not all brands are listed on this leaflet.


Benzocaine topical used in the mouth or throat may cause a life-threatening condition in which the amount of oxygen in your blood stream becomes dangerously low. This condition is called methemoglobinemia (met-HEEM-oh glo-bin-EE-mee-a) and it may occur after only one use of benzocaine or after several uses.

Signs and symptoms of methemoglobinemia may occur within minutes or up to 2 hours after using benzocaine topical in the mouth or throat. GET EMERGENCY MEDICAL HELP IF YOU HAVE ANY OF THESE SYMPTOMS: headache, tired feeling, confusion, fast heart rate, and feeling light-headed or short of breath, with a pale, blue, or gray appearance of your skin, lips, or fingernails.


Do not use benzocaine topical if you have ever had methemoglobinemia in the past. Do not use this medicine on a child younger than 2 years old without medical advice. An overdose of numbing medications can cause fatal side effects if too much of the medicine is absorbed through your skin and into your blood. This is more likely to occur when using a numbing medicine without the advice of a medical doctor (such as during a cosmetic procedure like laser hair removal). Overdose symptoms may include uneven heartbeats, seizure (convulsions), coma, slowed breathing, or respiratory failure (breathing stops).

Use the smallest amount of this medication needed to numb the skin or relieve pain. Do not use large amounts of benzocaine topical, or cover treated skin areas with a bandage or plastic wrap without medical advice. Be aware that many cosmetic procedures are performed without a medical doctor present.


Your body may absorb more of this medication if you use too much, if you apply it over large skin areas, or if you apply heat, bandages, or plastic wrap to treated skin areas. Skin that is cut or irritated may also absorb more topical medication than healthy skin.

Before using benzocaine topical, tell your doctor if you have any type of inherited enzyme deficiency, heart disease, a breathing disorder such as asthma, bronchitis, or emphysema, or if you smoke.


If you are treating a sore throat, call your doctor if the pain is severe or lasts longer than 2 days, especially if you also develop a fever, headache, skin rash, swelling, nausea, vomiting, cough, or breathing problems.


What should I discuss with my health care provider before using Orajel Denture Plus (benzocaine topical)?


Do not use benzocaine topical if you have ever had methemoglobinemia in the past. An overdose of numbing medications can cause fatal side effects if too much of the medicine is absorbed through your skin and into your blood. This is more likely to occur when using a numbing medicine without the advice of a medical doctor (such as during a cosmetic procedure like laser hair removal). Overdose symptoms may include uneven heartbeats, seizure (convulsions), coma, slowed breathing, or respiratory failure (breathing stops).

Ask a doctor or pharmacist if it is safe for you to take this medicine if you have:



  • asthma, bronchitis, emphysema, or other breathing disorder;




  • heart disease;




  • a personal or family history of methemoglobinemia, or any genetic (inherited) enzyme deficiency; or




  • if you smoke.




FDA pregnancy category C. It is not known whether benzocaine topical will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.. It is not known whether benzocaine topical passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Do not use this medicine on a child younger than 2 years old without medical advice.

How should I use Orajel Denture Plus (benzocaine topical)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.


Your body may absorb more of this medication if you use too much, if you apply it over large skin areas, or if you apply heat, bandages, or plastic wrap to treated skin areas. Skin that is cut or irritated may also absorb more topical medication than healthy skin.

Use the smallest amount of medicine needed to numb the skin or relieve pain. Do not use large amounts of benzocaine topical, or cover treated skin areas with a bandage or plastic wrap without medical advice. Be aware that many cosmetic procedures are performed without a medical doctor present.


This medication comes with instructions for safe and effective application. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.


To treat minor skin conditions, apply a thin layer of benzocaine topical to the affected area up to 4 times per day. If using the spray, hold the container 6 to 12 inches away from the skin. Do not spray this medication onto your face. Spray it instead on your hands and then rub it onto the face, avoiding contact with your eyes.


To treat hemorrhoids, clean the area with soap and water before applying benzocaine topical. Apply the medication up to 6 times per day. If you are using the rectal suppository, try to empty your bowel and bladder before inserting the suppository. Remove the outer wrapper from the suppository before inserting it. Avoid handling the suppository too long or it will melt in your hands.


Do not use benzocaine topical to treat large skin areas or deep puncture wounds. Avoid using the medicine on skin that is raw or blistered, such as a severe burn or abrasion.

Call your doctor if your symptoms do not improve or if they get worse within the first 7 days of using benzocaine topical. Also call your doctor if your symptoms had cleared up but then came back.


If you are treating a sore throat, call your doctor if the pain is severe or lasts longer than 2 days, especially if you also develop a fever, headache, skin rash, swelling, nausea, vomiting, cough, or breathing problems.


Store at room temperature away from moisture and heat. Do not freeze.

What happens if I miss a dose?


Since benzocaine topical is used as needed, you may not be on a dosing schedule. If you are using the medication regularly, use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. An overdose of benzocaine topical applied to the skin can cause life-threatening side effects such as uneven heartbeats, seizure (convulsions), coma, slowed breathing, or respiratory failure (breathing stops).

What should I avoid while taking Orajel Denture Plus (benzocaine topical)?


Avoid eating within 1 hour after using benzocaine topical on your gums or inside your mouth.


Benzocaine topical is for use only on the surface of your body, or just inside the mouth, vagina, or rectum. Avoid getting this medication in your eyes. Avoid swallowing the gel, liquid, or ointment while applying it to your gums or the inside of your mouth. The throat spray or oral lozenge may be swallowed gradually during use.

Do not apply other medications to the same affected areas you treat with benzocaine topical, unless your doctor has told you otherwise.


Orajel Denture Plus (benzocaine topical) side effects


Benzocaine topical used in the mouth or throat may cause a life-threatening condition in which the amount of oxygen in your blood stream becomes dangerously low. This condition is called methemoglobinemia (met-HEEM-oh glo-bin-EE-mee-a) and it may occur after only one use of benzocaine or after several uses.

Signs and symptoms may occur within minutes or up to 2 hours after using benzocaine topical in the mouth or throat. GET EMERGENCY MEDICAL HELP IF YOU HAVE:



  • headache, tired feeling, confusion;




  • fast heart rate;




  • feeling light-headed or short of breath; and




  • pale, blue, or gray appearance of your skin, lips, or fingernails.




Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using benzocaine topical and call your doctor at once if you have any of these other serious side effects:

  • headache, weakness, dizziness, breathing problems, fast heart rate, and gray or bluish colored skin (rare but serious side effects of benzocaine);




  • severe burning, stinging, or sensitivity where the medicine is applied;




  • swelling, warmth, or redness; or




  • oozing, blistering, or any signs of infection.



Less serious side effects may include:



  • mild stinging, burning, or itching where the medicine is applied;




  • skin tenderness or redness; or




  • dry white flakes where the medicine was applied.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Orajel Denture Plus (benzocaine topical)?


It is not likely that other drugs you take orally or inject will have an effect on topically applied benzocaine topical. But many drugs can interact with each other. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Orajel Denture Plus resources


  • Orajel Denture Plus Side Effects (in more detail)
  • Orajel Denture Plus Use in Pregnancy & Breastfeeding
  • 0 Reviews for Orajel Denture Plus - Add your own review/rating


  • Americaine Ointment MedFacts Consumer Leaflet (Wolters Kluwer)

  • Anacaine Advanced Consumer (Micromedex) - Includes Dosage Information

  • Anbesol Extra Strength Advanced Consumer (Micromedex) - Includes Dosage Information

  • Benz-O-Sthetic Gel MedFacts Consumer Leaflet (Wolters Kluwer)

  • Lanacane Aerosol Spray MedFacts Consumer Leaflet (Wolters Kluwer)

  • OraMagic Plus Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

  • Rid-A-Pain Topical Advanced Consumer (Micromedex) - Includes Dosage Information



Compare Orajel Denture Plus with other medications


  • Oral and Dental Conditions


Where can I get more information?


  • Your pharmacist can provide more information about benzocaine topical.

See also: Orajel Denture Plus side effects (in more detail)


Sunday, 6 September 2009

Emge




Emge may be available in the countries listed below.


Ingredient matches for Emge



Magnesium Hydrogen Aspartate

Magnesium Hydrogen Aspartate dihydrate (a derivative of Magnesium Hydrogen Aspartate) is reported as an ingredient of Emge in the following countries:


  • Germany

International Drug Name Search

Friday, 4 September 2009

Propatyl Nitrate




Propatyl Nitrate may be available in the countries listed below.


Ingredient matches for Propatyl Nitrate



Propatylnitrate

Propatyl Nitrate (USAN) is also known as Propatylnitrate (Rec.INN)

International Drug Name Search

Glossary

Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 3 September 2009

Carvedilol Pharmagenus




Carvedilol Pharmagenus may be available in the countries listed below.


Ingredient matches for Carvedilol Pharmagenus



Carvedilol

Carvedilol is reported as an ingredient of Carvedilol Pharmagenus in the following countries:


  • Spain

International Drug Name Search

Tuesday, 1 September 2009

Non-Preg




Non-Preg may be available in the countries listed below.


Ingredient matches for Non-Preg



Medroxyprogesterone

Medroxyprogesterone 17α-acetate (a derivative of Medroxyprogesterone) is reported as an ingredient of Non-Preg in the following countries:


  • Myanmar

International Drug Name Search

Thursday, 27 August 2009

Pravastatine Mylan




Pravastatine Mylan may be available in the countries listed below.


Ingredient matches for Pravastatine Mylan



Pravastatin

Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Pravastatine Mylan in the following countries:


  • Belgium

International Drug Name Search

Tuesday, 25 August 2009

Medicap




Medicap may be available in the countries listed below.


Ingredient matches for Medicap



Mefenamic Acid

Mefenamic Acid is reported as an ingredient of Medicap in the following countries:


  • Hong Kong

International Drug Name Search

Phenprobamate




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

M03BA01

CAS registry number (Chemical Abstracts Service)

0000673-31-4

Chemical Formula

C10-H13-N-O2

Molecular Weight

179

Therapeutic Categories

Anxiolytic agent

Muscle relaxant, centrally acting

Chemical Names

3-Phenyl-1-propanol carbamate (WHO)

Benzenepropanol, carbamate

Foreign Names

  • Phenprobamatum (Latin)
  • Phenprobamat (German)
  • Phenprobamate (French)
  • Fenprobamato (Spanish)

Generic Names

  • Phenprobamate (OS: JAN, DCF, BAN)
  • Actozine (IS)
  • MH 532 (IS)
  • Proformiphen (IS)

Brand Names

  • Extacol
    Shun Hwa, Taiwan


  • Gamaflex
    Abdi Ibrahim, Turkey


  • Gamakuil
    Embil, Turkey

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 23 August 2009

Phosex




Phosex may be available in the countries listed below.


UK matches:

  • Phosex 1000mg Tablets (SPC)

Ingredient matches for Phosex



Calcium Acetate

Calcium Acetate is reported as an ingredient of Phosex in the following countries:


  • Ireland

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.